FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Posted:
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
Science and research integrity has been facing a growing crisis. Mass retractions, manipulated peer review, authorship for sale, and complicit guest editors have shaken the publishing system and risk undermining public trust in the scientific record. Meanwhile, there have been huge…
Attendees
Sponsors and Exhibitors
Agenda 2025
Contact us